21-11-2011: Thermo Fisher Scientific Inc. announced the winner of the 2012 Winter Conference Award in Plasma Spectrochemistry, Dr. J. Sabine Becker, head of Trace and UltraTrace Analysis, Central Division of Analytical Chemistry at the Research Center Juelich, Germany. The award, which honors scientists who have made the most noteworthy contributions to the field of plasma spectrochemistry, is sponsored by Thermo Fisher. Thermo Fisher will present the award and a check for $5,000 to Dr. Becker during the 2012 Winter Conference on Plasma Spectrochemistry to be held in Tucson, Ariz. January 9–14, 2012.
Dr. Becker’s distinguished career in analytical chemistry has focused on long-lived radionuclides, ultratrace and high-purity materials analysis, isotope ratio measurements, and micro and nanolocal elemental and trace analyses. Recently she established BrainMet, an Analytical Center of Excellence at the Research Centre Juelich for brain research imaging. Based on laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS), BrainMet has introduced novel imaging techniques for metals, metalloids and non-metals in biological tissues. The approach provides quantitative mapping of essential and toxic elements in thin sections of diseased and healthy medical and biological tissue sections.
“As the leader in plasma spectrochemistry instrumentation, Thermo Fisher is pleased to sponsor an industry award that brings together the major figures in this field,” said Lothar Rottmann, global support manager, inorganic mass spectrometry at Thermo Fisher. “The Winter Conference award complements our objectives for advancement and innovation, and we look forward to honoring Dr. Becker for her remarkable achievements in this field.”
Entry is now open for the next Winter Plasma Award in 2014 and Thermo Fisher invites scientists worldwide to submit their applications.
Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as ... more
Thermo Fisher Scientific Inc. announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities to meet increa ... more
Thermo Fisher Scientific, Inc. and Immundiagnostik AG announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial assays to be widely applicable in research and routine cl ... more
Organizations have made significant investments in enterprise and laboratory tools, technologies and solutions to help improve productivity, better manage data/information and optimize their business processes. However, the reality is that most companies have not reaped the return on inves ... more
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech ... more